- Home
- BCRX vs TGI Comparison
BCRX vs TGI Comparison
Compare BCRX & TGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- TGI
- Stock Information
- Founded
- BCRX 1986
- TGI 1993
- Country
- BCRX United States
- TGI United States
- Employees
- BCRX N/A
- TGI N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- TGI Aerospace
- Sector
- BCRX Health Care
- TGI Industrials
- Exchange
- BCRX Nasdaq
- TGI Nasdaq
- Market Cap
- BCRX 1.7B
- TGI 2.0B
- IPO Year
- BCRX 1994
- TGI 1996
- Fundamental
- Price
- BCRX $10.75
- TGI $25.79
- Analyst Decision
- BCRX Buy
- TGI Hold
- Analyst Count
- BCRX 8
- TGI 8
- Target Price
- BCRX $16.75
- TGI $20.63
- AVG Volume (30 Days)
- BCRX 6.8M
- TGI 702.7K
- Earning Date
- BCRX 05-05-2025
- TGI 05-28-2025
- Dividend Yield
- BCRX N/A
- TGI N/A
- EPS Growth
- BCRX N/A
- TGI N/A
- EPS
- BCRX N/A
- TGI 0.52
- Revenue
- BCRX $503,485,000.00
- TGI $1,261,962,000.00
- Revenue This Year
- BCRX $36.61
- TGI $3.52
- Revenue Next Year
- BCRX $13.19
- TGI $11.43
- P/E Ratio
- BCRX N/A
- TGI $56.07
- Revenue Growth
- BCRX 41.67
- TGI 5.87
- 52 Week Low
- BCRX $5.92
- TGI $11.01
- 52 Week High
- BCRX $11.11
- TGI $25.86
- Technical
- Relative Strength Index (RSI)
- BCRX 64.20
- TGI 68.23
- Support Level
- BCRX $10.46
- TGI $25.61
- Resistance Level
- BCRX $11.00
- TGI $25.86
- Average True Range (ATR)
- BCRX 0.41
- TGI 0.09
- MACD
- BCRX -0.02
- TGI -0.01
- Stochastic Oscillator
- BCRX 77.78
- TGI 77.27
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.